Delivery Order SPE2DB22D1017-SPE2DB25FG6PB

Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,254.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication lisdexamfetamine 30 mg capsules. The contract has a performance period ending on June 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $3,436.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 capsules of the prescription medication lisdexamfetamine 20 mg. The contract has an ultimate completion date of July 3, 2025 and is not set aside for any socioeconomic category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a $1,160.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the prescription medication lisdexamfetamine 40 mg capsules. It has an ultimate completion date of July 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a $4,502.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100-count bottles of the prescription drug lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of July 8, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a $2,474.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 40 mg capsules in 100-count bottles. The contract has an ultimate completion date of June 10, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
This is a $1,070.16 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the drug lisdexamfetamine 20mg capsules, with a period of performance through May 28, 2025. This order is not associated with a set-aside program and was competed openly. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,185,890 units of the medication lisdexamfetamine 50 mg capsule in 100-count packages. The $2,584.29 firm fixed-price delivery order has a completion date of May 9, 2025 and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $2,140.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,979,063 units of 30mg lisdexamfetamine capsules, a prescription medication. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,355.37 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 60 mg. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lisdexamfetamine 20 mg capsules. The $1,029.60 contract has a completion date of July 3, 2025 and is not a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG6PB
    Delivery Order

This is a $3,264.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication lisdexamfetamine 20 mg capsules in 90-count packages. The order has a completion date of July 7, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract award does not have a set-aside designation, indicating open competition.

Generated 10/2/25, 11:13 AM